ORMP Oramed Pharmaceuticals Inc. - Common Stock
$4,83
Prix · Aoû 19, 2026
Données fondamentales au Aoû 10, 2026
Fourchette 52 semaines
$2–$5
89% of range
Note des analystes
HOLD
6 analysts
Objectif de cours
$6
+29% upside
P/E (TTM)
0.0
ROE
37.0%
Marge nette
3202.5%
À propos de Oramed Pharmaceuticals Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
Lire la suite
Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
History
Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.
Product pipeline
Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.
In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.
In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.
In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.
In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.
On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.
Subsidiaries
OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
ORMP Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$4.83
Capitalisation Boursière
$197.7K
P/E (TTM)
0.0
BPA (TTM)
$1.50
Revenus (TTM)
$2M
Rendement div.
—
ROE
37.0%
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $5
ORMP Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$2M
2017-08-31
→
2025-12-31
BPA
$1.50
2022-12-31
→
2025-12-31
Flux de trésorerie libre
$-9M
2019-08-31
→
2025-12-31
Marges
3202.5%
2025-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ORMP
Médiane des pairs
P/E (TTM)
0.0
23.4
P/S (TTM)
0.1
11.2
P/B
0.0
2.5
Price / FCF (Cours / FCF)
-0.0
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ORMP
Médiane des pairs
Gross Margin (Marge Brute)
0.65%
82.8%
Operating Margin (Marge d'exploitation)
-754.4%
—
Net Profit Margin (Marge nette)
3202.5%
-199.7%
ROA
33.2%
-34.8%
ROE
37.0%
-33.2%
ROIC
-6.4%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ORMP
Médiane des pairs
Current Ratio (Ratio de liquidité)
7.0
1.5
Quick Ratio (Ratio de liquidité réduite)
2.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ORMP
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-50.4%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-9.6%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ORMP
Médiane des pairs
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
—
Ratio de distribution
—
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 16 janvier 2026 | $0,2500 |
ORMP Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
VENTE
6 analystes
- Achat fort 0 0,0%
- Achat 0 0,0%
- Conserver 3 50,0%
- Vente 1 16,7%
- Vente forte 2 33,3%
Objectif de cours à 12 mois
1 analystes · 2026-08-17
Bas
$6.25
Haut
$6.25
Objectif médian
$6.25
+29,4%
Objectif moyen
$6.25
+29,4%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.32%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 décembre 2025 | $0.24 | $0.00 | 0.24% |
| 30 septembre 2025 | $1.12 | $-0.04 | 1.2% |
| 30 juin 2025 | $0.31 | $-0.04 | 0.35% |
| 31 mars 2025 | $-0.19 | $-0.01 | -0.18% |
| 31 décembre 2024 | $0.00 | $-0.03 | 0.03% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| NRXP | — | — | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | · | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Cost of Revenue | $2M | · | · | · | · | · | $90.0K | $-86.0K | $187.0K | |
| Gross Profit | $13.0K | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $6M | $9M | $28M | · | $10M | $14M | $12M | $10M | |
| SG&A Expense | $9M | $6M | $8M | $14M | · | $4M | $4M | $4M | $3M | |
| Operating Income | $-15M | $-13M | $-16M | $-41M | · | $-12M | $-15M | $-14M | $-11M | |
| Interest Expense | · | · | $2M | · | · | · | · | · | · | |
| Interest Income | · | · | $10.0K | · | · | · | · | · | · | |
| Other Non-op | $-606.0K | $-27.0K | $13.3K | $3M | · | · | · | · | · | |
| Pretax Income | $75M | $-16M | $5M | $-38M | · | $-12M | $-14M | $-13M | $-10M | |
| Income Tax | $11M | $3M | · | $100.0K | · | · | $300.0K | · | $400.0K | |
| Net Income | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| EPS (Basic) | $1.53 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| Shares (Basic) | 41,402,997 | 40,850,446 | 40,315,068 | 38,997,649 | · | · | · | · | · | |
| Shares (Diluted) | 42,418,644 | 40,850,446 | 40,566,901 | 38,997,649 | · | · | · | · | · | |
| EBITDA | $-15M | · | $-16M | $-41M | · | $-12M | $-15M | · | · |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $54M | $9M | $40M | · | $19M | $3M | $5M | $4M | |
| Short-term Investments | $5M | $3M | · | · | $8M | $3M | · | $5M | · | |
| Prepaid Expense | $3M | $1M | $537.0K | $1M | · | $611.0K | $1M | $574.0K | · | |
| Current Assets | $133M | $143M | $163M | $157M | $148M | $41M | $33M | $31M | · | |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $388.0K | $99.0K | $24.0K | $17.0K | · | |
| Other Non-current Assets | $44.0K | $32.0K | $27.0K | · | · | · | · | · | · | |
| Total Assets | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Accounts Payable | $443.0K | $789.0K | $551.0K | $4M | $5M | $2M | $3M | $2M | · | |
| Accrued Liabilities | $1M | $402.0K | $605.0K | · | · | · | · | · | · | |
| Short-term Debt | $652.0K | $329.0K | $51M | · | · | · | $3M | $2M | · | |
| Current Liabilities | $19M | $6M | $53M | $6M | $7M | $5M | $5M | $5M | · | |
| Capital Leases | $540.0K | $156.0K | $342.0K | $647.0K | $370.0K | $31.0K | · | · | · | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $60.0K | $63.0K | · | · | $211.0K | $271.0K | $313.0K | · | |
| Long-term Debt | · | · | · | $25.0K | $12M | · | $10M | $11M | · | |
| Total Debt | · | · | $51M | · | · | · | $3M | · | · | |
| Common Stock | $472.0K | $480.0K | $485.0K | $476.0K | $459.0K | $284.0K | $208.0K | $207.0K | · | |
| Paid-in Capital | · | · | · | $314M | $293M | $125M | · | · | · | |
| Retained Earnings | $-123M | $-177M | $-158M | $-163M | $-127M | $-93M | $-81M | $-69M | · | |
| AOCI | · | · | · | · | · | · | · | $702.0K | · | |
| Stockholders' Equity | $200M | $145M | $164M | $152M | $166M | $33M | $19M | $31M | $19M | |
| Liabilities + Equity | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Shares Outstanding | 39,275,006 | 39,920 | 40,339,000 | 39,564,000 | 38,158 | 23,675,530 | 17,383,359 | 17,369,875 | · |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $12M | · | $465.0K | $808.0K | $2M | $2M | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-10M | $-28M | · | $-12M | $-13M | $-15M | $-6M | |
| CapEx | $9.0K | $18.0K | $254.0K | $496.0K | · | $82.0K | $15.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $5M | $106M | $-73M | $30M | · | $5M | $11M | $-7M | $4M | |
| Stock Issued | · | · | $2M | $12M | · | · | · | · | · | |
| Stock Repurchased | $5M | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | $-5M | · | $2M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $-52M | $52M | $11M | · | $24M | · | $23M | $2M | |
| Net Change in Cash | $-8M | $45M | $-31M | $13M | · | $16M | $-2M | $1M | $62.0K | |
| Taxes Paid | · | $2M | · | $2M | · | · | $300.0K | · | $400.0K | |
| Free Cash Flow | $-9M | · | $-11M | $-28M | · | $-13M | $-13M | · | · |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.65% | · | · | · | · | · | · | · | · | |
| Operating Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| Net Margin | 3202.5% | · | 412.3% | -1397.1% | · | -424.8% | -531.1% | · | · | |
| Pretax Margin | 3766.2% | · | 379.7% | · | · | -424.8% | -520.0% | · | · | |
| EBITDA Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| ROA | 33.2% | · | 2.9% | -22.2% | · | -29.0% | -35.0% | · | · | |
| ROE | 37.0% | · | 3.5% | -23.7% | · | -47.0% | -70.1% | · | · | |
| ROIC | -6.4% | · | · | · | · | · | -67.6% | · | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 3.1 | 27.3 | · | 8.9 | 6.3 | · | · | |
| Quick Ratio | 2.7 | · | 1.3 | 0.7 | · | 5.0 | 1.3 | · | · | |
| Debt / Equity | · | · | 0.3 | · | · | · | 0.1 | · | · | |
| Interest Coverage | · | · | -7.7 | · | · | · | · | · | · |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -50.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -9.6% | · | · | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Net Income TTM | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| Market Cap | $112M | · | $93M | $476M | · | $83M | $58M | · | · | |
| Enterprise Value | · | · | $77M | · | · | · | $53M | · | · | |
| P/E | 1.9 | -5.0 | 16.5 | -12.8 | · | · | · | · | · | |
| P/S | 56.0 | · | 69.5 | 176.1 | · | 30.5 | 21.4 | · | · | |
| P/B | 0.6 | · | 0.6 | 3.1 | · | 2.5 | 3.0 | · | · | |
| P / Tangible Book | 0.6 | 0.7 | 0.6 | 3.1 | · | 2.5 | · | · | · | |
| P / Cash Flow | -12.2 | · | -9.1 | -17.0 | · | -6.6 | -4.5 | · | · | |
| P / FCF | -12.2 | · | -8.8 | -16.8 | · | -6.6 | -4.5 | · | · | |
| EV / EBITDA | · | · | -4.9 | · | · | · | -3.6 | · | · | |
| EV / FCF | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| EV / Revenue | · | · | 57.8 | · | · | · | 19.8 | · | · | |
| Earnings Yield | 52.6% | -19.8% | 6.1% | -7.8% | · | · | · | · | · |
Compte de résultat 17
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | · | · | $2M | · | · | · | · | $0 | · | $674.0K | $666.0K | $681.0K | $682.0K | |
| Cost of Revenue | · | · | $0 | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $0 | · | · | $13.0K | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $2M | $2M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $2M | $957.0K | $2M | $4M | $7M | $5M | |
| SG&A Expense | $3M | $2M | $4M | $1M | $1M | $2M | $2M | $847.0K | $2M | $2M | $2M | $3M | $2M | $1M | $3M | $3M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Operating Income | $-3M | $-4M | $-6M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-5M | $-10M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $592.0K | · | $826.0K | · | · | · | · | |
| Other Non-op | $-4.0K | $-100.0K | $-74M | $61M | · | $-143.0K | $-2M | $-15M | $14M | $4M | $-4M | $435.0K | $2M | $2M | $1M | $1M | |
| Pretax Income | $102M | $49M | $10M | $59M | $13M | $-7M | $-10M | $-19M | $11M | $2M | $13M | $-3M | $-1M | · | $-9M | $-7M | |
| Income Tax | $23M | $11M | $-212.0K | $11M | $-126.0K | $584.0K | $416.0K | $1M | $2M | · | · | · | · | · | $0 | $100.0K | |
| Net Income | $78M | $38M | $10M | $48M | $13M | $-8M | $-10M | $-20M | $9M | $2M | $13M | $-3M | $-1M | $-3M | $-8M | $-7M | |
| EPS (Basic) | $1.90 | $0.94 | $0.24 | $1.16 | $0.32 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| EPS (Diluted) | $1.84 | $0.91 | $0.25 | $1.13 | $0.31 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| Shares (Basic) | 41,040,479 | 40,773,866 | -83,325,572 | 41,756,301 | 41,743,486 | 41,228,782 | -81,842,111 | 40,896,845 | 40,959,759 | 40,835,953 | -80,397,680 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| Shares (Diluted) | 42,501,252 | 41,970,186 | -84,194,067 | 42,774,504 | 42,609,425 | 41,228,782 | -83,201,413 | 40,896,845 | 41,591,007 | 41,564,007 | -80,145,847 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M | $-5M | · | $-8M |
Bilan 22
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $13M | $46M | $52M | $16M | · | $54M | · | $10M | $19M | · | · | · | · | $40M | · | |
| Short-term Investments | $846.0K | $5M | $5M | $5M | $2M | $4M | $3M | $57M | $66M | $78M | · | $49.4K | $943.0K | $2M | · | $5M | |
| Prepaid Expense | $2M | $2M | $3M | $1M | $1M | $832.0K | $1M | $474.0K | $533.0K | $501.0K | $537.0K | $666.0K | $769.0K | · | $1M | · | |
| Current Assets | $53M | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M | $177M | $163M | $176M | $151M | $155M | $157M | $160M | |
| PP&E (Net) | $532.0K | $561.0K | $586.0K | $614.0K | $645.0K | $671.0K | $698.0K | $718.0K | $765.0K | $819.0K | $873.0K | $923.0K | $945.0K | $977.0K | $815.0K | $535.0K | |
| Other Non-current Assets | $49.0K | $46.0K | $44.0K | $40.0K | $38.0K | $32.0K | $32.0K | · | · | · | $27.0K | · | · | · | · | · | |
| Total Assets | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Accounts Payable | $374.0K | $481.0K | $443.0K | $560.0K | $715.0K | $509.0K | $789.0K | $5M | $3M | $1M | $551.0K | $3M | $828.0K | $4M | $4M | $4M | |
| Accrued Liabilities | $1M | $1M | $1M | $585.0K | $841.0K | $800.0K | $402.0K | · | · | · | $605.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | $51M | $75M | $3.0K | $1.0K | · | · | |
| Current Liabilities | $11M | $11M | $19M | $6M | $4M | $5M | $6M | $5M | $4M | $34M | $53M | $78M | $1M | $5M | $6M | $7M | |
| Capital Leases | $484.0K | $493.0K | $540.0K | $589.0K | $648.0K | $120.0K | $156.0K | $186.0K | $236.0K | $272.0K | $342.0K | $389.0K | $488.0K | $564.0K | $647.0K | $672.0K | |
| Deferred Tax | $40M | $18M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $60.0K | $60.0K | $60.0K | · | $63.0K | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $75M | · | · | · | $5M | |
| Total Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | · | $75M | $3.0K | $1.0K | · | · | |
| Common Stock | $495.0K | $491.0K | $472.0K | $490.0K | $491.0K | $491.0K | $480.0K | $484.0K | $488.0K | $487.0K | $485.0K | $484.0K | $484.0K | $481.0K | $476.0K | $470.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | $319M | $317M | · | $308M | |
| Retained Earnings | $-7M | $-85M | $-123M | $-123M | $-171M | $-184M | $-177M | $-166M | $-147M | $-156M | $-158M | $-171M | $-168M | $-166M | $-163M | $-155M | |
| Stockholders' Equity | $317M | $238M | $200M | $203M | $155M | $141M | $146M | $156M | $177M | $167M | $164M | $149M | $152M | $151M | $152M | $154M | |
| Liabilities + Equity | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Shares Outstanding | 41,314,211 | 40,926,081 | 39,275,006 | 40,838,226 | 40,845,087 | 40,850,455 | 39,919,545 | 40,209,575 | 40,628,924 | 40,519,160 | 40,338,979 | 40,282,688 | 40,219,396 | 39,969,979 | 39,563,888 | 39,113,236 |
Flux de trésorerie 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $719.0K | $800.0K | $2M | $1M | $301.0K | $1M | $1M | $1M | $852.0K | $2M | $173.0K | $3M | $3M | |
| Deferred Tax | $22M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-200.0K | $-3M | $-466.0K | $-2M | $-4M | $-4M | $-2M | $-7M | $2M | $-1M | $-1M | $-694.0K | $-3M | $-6M | $-8M | $-2M | |
| CapEx | $2.0K | $5.0K | $2.0K | $0 | $4.0K | $3.0K | $11.0K | $5.0K | $0 | $2.0K | $3.0K | $32.0K | $20.0K | $199.0K | $308.0K | $121.0K | |
| Investing Cash Flow | $4M | $-19M | $-2M | $38M | $-55M | $24M | $15M | $-34M | $95M | $30M | $30M | $-75M | $-15M | $-13M | $11M | $1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-2.0K | $0 | $2M | $4M | $-3M | |
| Stock Repurchased | · | · | $4M | $361.0K | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $78.0K | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-10M | $-4M | $-361.0K | · | · | $-1M | $-1M | $-31M | $-19M | $-25M | $75M | $0 | $2M | $4M | $4M | |
| Net Change in Cash | $2M | $-33M | $-6M | $36M | $-59M | $20M | $12M | $-43M | $66M | $10M | $4M | $-1M | $-17M | $-16M | $7M | $3M | |
| Taxes Paid | · | · | · | $-7M | · | · | · | · | · | · | · | $527.0K | $3M | $308.0K | · | $167.0K | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-6M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.65% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| Net Margin | · | · | · | · | · | -382.1% | · | · | · | · | · | · | -177.2% | -542.2% | · | -1063.5% | |
| Pretax Margin | · | · | · | · | · | -352.9% | · | · | · | · | · | · | · | · | · | -1048.8% | |
| EBITDA Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| ROA | 29.4% | 18.4% | · | 25.1% | 7.7% | -4.3% | · | -9.9% | 5.4% | 0.85% | · | -1.6% | -0.75% | -2.2% | · | -5.9% | |
| ROE | 33.1% | 20.2% | · | 26.9% | 8.0% | -5.0% | · | -12.8% | 5.6% | 0.97% | · | -2.1% | -0.78% | -2.3% | · | -6.5% | |
| ROIC | -0.67% | -1.2% | · | -0.97% | -1.6% | -3.5% | · | -2.1% | -1.5% | · | · | · | · | · | · | -5.4% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 6.5 | · | 22.2 | 26.8 | 23.9 | · | 27.1 | 41.1 | 5.3 | · | 2.2 | 141.5 | 31.2 | · | 24.5 | |
| Quick Ratio | 1.5 | 1.7 | · | 9.3 | 4.8 | 0.7 | · | 10.9 | 20.4 | 2.9 | · | 0.0 | 0.9 | 0.5 | · | 0.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.2 | · | 0.5 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -3.5 | · | · | · | · |
Efficacité 1
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 |
Valorisation (TTM) 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $178M | $92M | · | $34M | $-5M | $-17M | · | $-12M | $6M | $-6M | · | $-15M | $-22M | $-32M | · | $-36M | |
| Market Cap | $199M | $139M | · | $108M | $92M | $87M | · | $98M | $104M | $118M | · | $105M | $144M | $87M | · | $253M | |
| Enterprise Value | · | · | · | $51M | $74M | · | · | · | · | $54M | · | · | · | · | · | · | |
| P/E | 1.1 | 1.6 | · | 3.4 | -16.1 | -5.2 | · | -8.1 | 17.1 | -19.5 | · | -261.0 | 10.5 | 3.4 | · | 7.0 | |
| P/S | · | · | · | · | · | · | · | 36.4 | 38.7 | 43.9 | · | 39.0 | 53.4 | 32.4 | · | 94.0 | |
| P/B | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Cash Flow | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.2 | · | · | · | -15.7 | · | · | |
| P / FCF | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.1 | · | · | · | -15.2 | · | · | |
| EV / EBITDA | · | · | · | -20.9 | -29.9 | · | · | · | · | -18.2 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -36.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 20.0 | · | · | · | · | · | · | |
| Earnings Yield | 87.1% | 63.5% | · | 29.2% | -6.2% | -19.2% | · | -12.3% | 5.8% | -5.1% | · | -0.38% | 9.5% | 29.4% | · | 14.3% | |
| Payout Ratio | · | 27.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $2M | — | $1M | $3M | — |
| Marge Brute % | 0.65% | — | — | — | — |
| Marge d'exploitation % | -754.4% | — | -1176.8% | -1502.0% | — |
| Résultat net | $64M | $-19M | $5M | $-37M | — |
| BPA dilué | $1.50 | $-0.48 | $0.14 | $-0.94 | — |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | — | — | 0.3 | — | — |
| Ratio de liquidité | 7.0 | — | 3.1 | 27.3 | — |
| Ratio de liquidité réduite | 2.7 | — | 1.3 | 0.7 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-9M | — | $-11M | $-28M | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 88 déclarants · $64.4M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 30 (+13 vs T. préc.) | 8 (0 vs T. préc.) | 19 (-1 vs T. préc.) | 19 (+5 vs T. préc.) | -209K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | $12 083 562 | 2 512 175 | 18,77% | Actions |
| Gem Investment Advisors, LLC | $9 614 238 | 1 998 802 | 14,94% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $9 189 697 | 1 910 540 | 14,28% | Actions |
| Murchinson Ltd. | $6 206 314 | 1 290 294 | 9,64% | Actions |
| SB Capital Management Inc | $5 415 000 | 1 900 000 | 8,41% | Actions |
| BML Capital Management, LLC | $4 166 754 | 866 269 | 6,47% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $2 783 249 | 578 638 | 4,32% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $2 162 008 | 449 482 | 3,36% | Actions |
| STATE STREET CORP | $1 164 501 | 242 100 | 1,81% | Actions |
| Rathbones Group PLC | $1 120 816 | 233 018 | 1,74% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 105 732 | 229 882 | 1,72% | Actions |
| GOLDMAN SACHS GROUP INC | $950 908 | 197 694 | 1,48% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $884 078 | 183 800 | 1,37% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $784 896 | 163 180 | 1,22% | Actions |
| STRS OHIO | $643 578 | 133 800 | 1,00% | Actions |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $495 247 | 102 962 | 0,77% | Actions |
| JANE STREET GROUP, LLC | $470 606 | 97 839 | 0,73% | Actions |
| Hillsdale Investment Management Inc. | $429 533 | 89 300 | 0,67% | Actions |
| RITHOLTZ WEALTH MANAGEMENT | $405 709 | 84 347 | 0,63% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $402 280 | 83 634 | 0,63% | Actions |
| AMERICAN CENTURY COMPANIES INC | $287 518 | 59 775 | 0,45% | Actions |
| XTX Topco Ltd | $240 130 | 49 923 | 0,37% | Actions |
| Nuveen, LLC | $223 203 | 46 404 | 0,35% | Actions |
| DEUTSCHE BANK AG\ | $159 682 | 33 198 | 0,25% | Actions |
| PRELUDE CAPITAL MANAGEMENT, LLC | $157 350 | 32 713 | 0,24% | Actions |
| BAILARD, INC. | $156 219 | 32 478 | 0,24% | Actions |
| RHUMBLINE ADVISERS | $147 281 | 30 621 | 0,23% | Actions |
| Bank of New York Mellon Corp | $143 016 | 29 733 | 0,22% | Actions |
| ALGERT GLOBAL LLC | $139 288 | 28 958 | 0,22% | Actions |
| WELLS FARGO & COMPANY/MN | $137 080 | 28 499 | 0,21% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $121 246 | 25 207 | 0,19% | Actions |
| CITADEL ADVISORS LLC | $120 250 | 25 000 | 0,19% | Option d'achat |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107 263 | 22 300 | 0,17% | Actions |
| MILLENNIUM MANAGEMENT LLC | $105 151 | 21 861 | 0,16% | Actions |
| PNC Financial Services Group, Inc. | $101 972 | 21 200 | 0,16% | Actions |
| Redwood Family Wealth LLC | $99 783 | 20 745 | 0,16% | Actions |
| BANK OF AMERICA CORP /DE/ | $91 621 | 19 048 | 0,14% | Actions |
| MORGAN STANLEY | $87 994 | 18 294 | 0,14% | Actions |
| Sage Capital Management, LLC | $86 474 | 17 977 | 0,13% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $75 378 | 15 671 | 0,12% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $67 811 | 14 098 | 0,11% | Actions |
| CITIGROUP INC | $66 590 | 13 844 | 0,10% | Actions |
| JPMORGAN CHASE & CO | $65 461 | 14 108 | 0,10% | Actions |
| Invesco Ltd. | $65 272 | 13 570 | 0,10% | Actions |
| Y-Intercept (Hong Kong) Ltd | $61 650 | 12 817 | 0,10% | Actions |
| Engineers Gate Manager LP | $61 077 | 12 698 | 0,09% | Actions |
| Altshuler Shaham Ltd | $53 925 | 11 211 | 0,08% | Actions |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $52 096 | 12 895 | 0,08% | Actions |
| Glass Jacobson Investment Advisors llc | $50 698 | 10 540 | 0,08% | Actions |
| Police & Firemen's Retirement System of New Jersey | $50 115 | 10 419 | 0,08% | Actions |
| MARSHALL WACE, LLP | $50 024 | 10 400 | 0,08% | Actions |
| Hudson Bay Capital Management LP | $49 375 | 10 265 | 0,08% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $47 706 | 9 918 | 0,07% | Actions |
| Steward Partners Investment Advisory, LLC | $42 453 | 8 826 | 0,07% | Actions |
| BARCLAYS PLC | $27 917 | 5 804 | 0,04% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $25 974 | 5 400 | 0,04% | Actions |
| NORTHERN TRUST CORP | $25 503 | 5 302 | 0,04% | Actions |
| Tower Research Capital LLC (TRC) | $23 218 | 4 827 | 0,04% | Actions |
| OSAIC HOLDINGS, INC. | $20 283 | 4 217 | 0,03% | Actions |
| FEDERATED HERMES, INC. | $19 221 | 3 996 | 0,03% | Actions |
| N.E.W. Advisory Services LLC | $16 495 | 3 429 | 0,03% | Actions |
| Legal & General Group Plc | $15 979 | 3 322 | 0,02% | Actions |
| CITADEL ADVISORS LLC | $15 565 | 3 236 | 0,02% | Actions |
| Ameritas Investment Partners, Inc. | $14 853 | 3 088 | 0,02% | Actions |
| HUNTINGTON NATIONAL BANK | $14 440 | 3 002 | 0,02% | Actions |
| Pioneer Family Office, LLC | $14 430 | 3 000 | 0,02% | Actions |
| Russell Investments Group, Ltd. | $13 088 | 2 721 | 0,02% | Actions |
| UBS Group AG | $12 987 | 2 700 | 0,02% | Actions |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7 576 | 1 575 | 0,01% | Actions |
| MetLife Investment Management, LLC | $7 037 | 1 463 | 0,01% | Actions |
| BlackRock, Inc. | $6 768 | 1 407 | 0,01% | Actions |
| ROYAL BANK OF CANADA | $6 000 | 1 246 | 0,01% | Actions |
| MCF Advisors LLC | $5 162 | 1 073 | 0,01% | Actions |
| Caitlin John, LLC | $4 810 | 1 000 | 0,01% | Actions |
| McIlrath & Eck, LLC | $3 400 | 1 000 | 0,01% | Actions |
| Sterling Capital Management LLC | $3 300 | 686 | 0,01% | Actions |
| IFP Advisors, Inc | $2 405 | 500 | 0,00% | Actions |
| PROEQUITIES, INC. | $2 310 | 1 000 | 0,00% | Actions |
| Golden State Wealth Management, LLC | $1 458 | 303 | 0,00% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $999 | 214 | 0,00% | Actions |
| HRT FINANCIAL LP | $469 | 97 582 | 0,00% | Actions |
| FMR LLC | $332 | 69 | 0,00% | Actions |
| SBI Securities Co., Ltd. | $284 | 59 | 0,00% | Actions |
| PRICE T ROWE ASSOCIATES INC /MD/ | $135 | 27 909 | 0,00% | Actions |
| TrinityBridge Ltd | $56 | 11 675 | 0,00% | Actions |
| HARBOUR INVESTMENTS, INC. | $48 | 10 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $29 | 6 | 0,00% | Actions |
| ACADIAN ASSET MANAGEMENT LLC | $8 | 1 691 | 0,00% | Actions |
Initiés de la société 30 initiés · 13 dirigeants · 16 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Nadav Kidron | President and CEO | 30 mars 2026 F | 3 422 243 | 0 | 0 | $0 |
| Avraham Gabay | Chief Financial Officer | 1 juillet 2026 S | 671 785 | 0 | 1 | $-330 854 |
| David Silberman | Chief Financial Officer | 4 janvier 2024 A | 366 500 | 0 | 0 | $0 |
| Hilla Eisenberg | CFO, Treasurer and Secretary | 26 février 2019 A | — | 0 | 0 | $0 |
| Yifat Hen Zommer | CFO, Treasurer and Secretary | 30 juin 2017 A | 46 560 | 0 | 0 | $0 |
| Chaime Orlev | CFO, Treasurer and Secretary | 12 octobre 2008 A | — | 0 | 0 | $0 |
| Joshua Hexter | COO & CBO | 2 juillet 2026 M | 1 073 384 | 0 | 1 | $-611 020 |
| Miriam Kidron | Chief Scientific Officer | 30 mars 2026 F | 1 133 138 | 0 | 0 | $0 |
| Netanel Derovan | Chief Legal Officer | 26 mai 2023 A | 149 500 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 janvier 2023 S | 126 143 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 janvier 2022 A | 109 468 | 0 | 0 | $0 |
| Mark Daniel Hasleton | VP Business Development | 26 février 2019 A | — | 0 | 0 | $0 |
| Ronald Edward Law | Chief Strategy Officer | 20 mars 2017 A | — | 0 | 0 | $0 |
| Yehuda Reznick | Administrateur | 31 décembre 2025 A | 105 180 | 0 | 0 | $0 |
| Daniel Aghion | Administrateur | 31 décembre 2025 A | 113 441 | 0 | 0 | $0 |
| Benjamin Shapiro | Administrateur | 31 décembre 2025 A | 123 220 | 0 | 0 | $0 |
| Arie Mayer | Administrateur | 31 décembre 2025 A | 168 009 | 0 | 0 | $0 |
| Leonard Sank | Administrateur | 5 juin 2025 A | 134 531 | 0 | 0 | $0 |
| Yadin Rozov | Administrateur | 4 janvier 2024 A | 155 320 | 0 | 0 | $0 |
| Kevin Rakin | Administrateur | 21 mars 2022 S | 46 661 | 0 | 0 | $0 |
| Aviad Friedman | Administrateur | 3 janvier 2022 G | 0 | 0 | 0 | $0 |
| Gao Xiaoming | Administrateur | 8 janvier 2020 A | — | 0 | 0 | $0 |
| David Mark Slager | Administrateur | 15 avril 2019 A | 1 316 328 | 0 | 0 | $0 |
| Xiaopeng Li | Administrateur | 2 août 2017 P | 206 350 | 0 | 0 | $0 |
| Harold Jacob | Administrateur | 10 mars 2016 S | 16 396 | 0 | 0 | $0 |
| Michael Berelowitz | Administrateur | 9 décembre 2015 S | 22 896 | 0 | 0 | $0 |
| Gerald M Ostrov | Administrateur | 23 février 2015 A | 24 896 | 0 | 0 | $0 |
| REGALS CAPITAL MANAGEMENT LP | Détenteur de 10% | 23 décembre 2015 X | 1 186 823 | 0 | 0 | $0 |
| Zeev Bronfeld | Détenteur de 10% | 27 septembre 2011 S | 5 808 517 | 0 | 0 | $0 |
| Michael Young | — | 27 mai 2004 S | 0 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 9 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 22 juillet 2026 | 3,30% | Amendement | — | SEC |
| Nadav Kidron ×8 dépôts | 28 août 2025 | 7,60% | Amendement | — | SEC |
| Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 dépôts | 20 juillet 2018 | — | Dépôt initial | — | SEC |
| Hefei Tianhui Incubator of Technologies Co., Ltd | 6 janvier 2016 | — | Dépôt initial | — | SEC |
| Leonard Sank | 15 décembre 2014 | — | Dépôt initial | Investissement passif | SEC |
| Miriam Kidron ×2 dépôts | 3 février 2014 | — | Dépôt initial | — | SEC |
| Zeev Bronfeld | 6 mars 2006 | — | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée | 10 juin 2004 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 10 juin 2004 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 14 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 114 970 SH | 8 août 2026 | Quotidien |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 7 046 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29 637 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,01% | 315 439 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28 155 NS | 31 mai 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 621 705 SH | 8 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,00% | 26 896 NS | 30 avril 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 523 NS | 30 avril 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 36 536 NS | 30 avril 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 4 152 NS | 31 mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3 431 NS | 30 avril 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 196 765 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 480 SH | 8 août 2026 | Quotidien |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 30 avril 2026 | N-PORT |